In addition, a reporter assay in human T-ALL cell lines indicated that the GIMAP enhancer is activated by TAL1 and its regulatory partners (GATA3 and RUNX1) and is repressed by E-proteins (E2A and HEB). The gene discussed is GATA3; the disease is acute lymphoblastic leukemia.